02181 MABPHARM-B
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.17X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 220.2% | Net Margin | N/A |
| Total Debt/Equity | 329.6% | Return on Equity | N/A |
| Price/Book | 21.83X | Return on Assets | N/A |
| (HKD 0.500) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | -136.07 | -230.75 | -236.37 | -356.83 | -219.12 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +41.0 | +2.4 | +33.8 | -62.9 | +3.2 |
| Earnings Per Share (HKD) | -0.033 | -0.056 | -0.057 | -0.087 | -0.053 |
| Earnings Per Share Growth (%) | +41.1 | +2.3 | +33.8 | -62.9 | +10.8 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 0.023 | 0.055 | 0.109 | 0.179 | 0.254 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 258.228 | 87.161 | +196.3 | 55.918 |
| Operating Result | -127.947 | -209.356 | -38.9 | -210.852 |
| Profit Before Taxation | -127.947 | -209.356 | -38.9 | -210.819 |
| Profit /( Loss) After Taxation | -127.947 | -209.356 | -38.9 | -210.819 |
| Net Profit | -127.947 | -209.356 | -38.9 | -210.819 |
| Earnings Per Share () | -0.0330 | -0.0560 | -41.1 | -0.0573 |
| Announcement Date | 2025-03-26 | 2024-03-26 | NA | 2023-03-24 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
